John Hoekman serves as Executive at IMPEL NEUROPHARMA INC, where they oversee executive responsibilities. Since joining the company, John Hoekman has executed 4 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 22, 2021 involved exercising options for 20,000 shares valued at $32.8K.
John Hoekman currently holds 128,221 shares of IMPEL NEUROPHARMA INC (IMPL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Hoekman has been a net neutral trader of IMPL stock. They have purchased $0 and sold $0 worth of shares.
John Hoekman's most recent insider trade was on Dec 22, 2021, when they sold 20,000 shares at $1.64 per share.
Get notified when new Form 4 filings are submitted
| 4,523 |
| $N/A |
| Discretionary |
| Apr 27, 2021 | IMPL | $0 | Other | 275 | $N/A | Discretionary |
| Apr 27, 2021 | IMPL | $0 | Conversion | 4,253 | $N/A | Discretionary |